Goldberg Andrew D. has filed 18 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 11706270 shares of ACHIEVE LIFE SCIENCES, INC. ($ACHV) on April 18, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 18, 2026 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Goldberg Andrew D. | CEO and President | A | Performance Restricted Stock Unit (PRSU) | 11706270 | $0.00 | 11,706,270.0000 | 53,233,988 | 9999.99% | 21.99% |
| April 18, 2026 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Goldberg Andrew D. | CEO and President | A | Stock Option (right to buy) | 3601929 | $0.00 | 3,601,929.0000 | 53,233,988 | 9999.99% | 6.77% |
| April 18, 2026 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Goldberg Andrew D. | CEO and President | A | Restricted Stock Unit (RSU) | 1800965 | $0.00 | 1,800,965.0000 | 53,233,988 | 9999.99% | 3.38% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.01% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 3350 | $0.00 | 16,700.0000 | 37,604,538 | 25.09% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 4540 | $0.00 | 4,540.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 2954 | $0.00 | 2,954.0000 | 37,604,538 | 9999.99% | 0.01% |
| March 7, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Stock Option (right to buy) | 7000 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.02% |
| March 7, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 7000 | $12.89 | 13,350.0000 | 37,604,538 | 110.24% | 0.02% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 29,383,276 | 100.00% | 0.01% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 3350 | $0.00 | 6,350.0000 | 29,383,276 | 111.67% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 29,383,276 | 9999.99% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 29,383,276 | 9999.99% | 0.02% |
| Dec. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | P | Common Stock | 1000 | $18.96 | 3,000.0000 | 24,619,700 | 50.00% | 0.00% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 24,619,700 | 9999.99% | 0.01% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 24,619,700 | 9999.99% | 0.02% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 24,619,700 | 100.00% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 2000 | $0.00 | 2,000.0000 | 24,619,700 | 9999.99% | 0.01% |